(Q71524734)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

Must erythropoietin be injected by the subcutaneous route for every hemodialyzed patient? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

J S Virot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

G Janin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

J Guillaumie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

P Michel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

P Dubot

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

D Chevet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

G Rifle

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

400-408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

[Correction of anemia with human recombinant erythropoietin in a pregnant woman with renal failure]

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Treatment of patients with anemia of malignancy with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Erythropoietin and the myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Recombinant human erythropoietin for anemia of end-stage renal failure in beta thalassemia trait

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

The role of recombinant human erythropoietin in the management of anemia associated with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Subcutaneous erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

State of the Art Lecture: Historical review on the use of recombinant human erythropoietin in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Investigating erythropoietin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Worsening of anemia induced by long-term use of captopril in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Vasculitis in haemodialysis: a new form of resistance to erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Efficacy comparison of intravenous and subcutaneous recombinant human erythropoietin administration in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Daily self-administered subcutaneous erythropoietin: benefits in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Pharmacokinetics and Dose Response after Intravenous and Subcutaneous Administration of Recombinant Erythropoietin in Patients on Regular Haemodialysis Treatment or Continuous Ambulatory Peritoneal Dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Recombinant human erythropoietin in anemic patients on maintenance hemodialysis: comparison between intravenous and subcutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Keynote Lecture: Starting r-HuEPO in chronic renal failure: when, why, and how?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

rhEPO treatment of anemia in uremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

Pain at the injection site of subcutaneously administered erythropoietin in maintenance hemodialysis patients: a comparison of two brands of erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990498-9

7 January 2021

10.1016/S0272-6386(96)90498-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8804239%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference